Global IBS-C Drug Market Insights, Forecast to 2031

Report ID: 1667241 | Published Date: Feb 2026 | No. of Page: 72 | Base Year: 2025 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Study Coverage
    1.1 IBS-C Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global IBS-C Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Amitiza
        1.2.3 Lactulose
        1.2.4 Milk of Magnesia
        1.2.5 LINZESS (Linaclotide)
        1.2.6 Others
    1.3 Market by Distribution Channel
        1.3.1 Global IBS-C Drug Market Size Growth Rate by Distribution Channel, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global IBS-C Drug Sales Estimates and Forecasts 2017-2028
    2.2 Global IBS-C Drug Revenue Estimates and Forecasts 2017-2028
    2.3 Global IBS-C Drug Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global IBS-C Drug Sales by Region
        2.4.1 Global IBS-C Drug Sales by Region (2017-2022)
        2.4.2 Global Sales IBS-C Drug by Region (2023-2028)
    2.5 Global IBS-C Drug Revenue by Region
        2.5.1 Global IBS-C Drug Revenue by Region (2017-2022)
        2.5.2 Global IBS-C Drug Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global IBS-C Drug Sales by Manufacturers
        3.1.1 Global Top IBS-C Drug Manufacturers by Sales (2017-2022)
        3.1.2 Global IBS-C Drug Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of IBS-C Drug in 2021
    3.2 Global IBS-C Drug Revenue by Manufacturers
        3.2.1 Global IBS-C Drug Revenue by Manufacturers (2017-2022)
        3.2.2 Global IBS-C Drug Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by IBS-C Drug Revenue in 2021
    3.3 Global IBS-C Drug Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global IBS-C Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global IBS-C Drug Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global IBS-C Drug Sales by Type
        4.1.1 Global IBS-C Drug Historical Sales by Type (2017-2022)
        4.1.2 Global IBS-C Drug Forecasted Sales by Type (2023-2028)
        4.1.3 Global IBS-C Drug Sales Market Share by Type (2017-2028)
    4.2 Global IBS-C Drug Revenue by Type
        4.2.1 Global IBS-C Drug Historical Revenue by Type (2017-2022)
        4.2.2 Global IBS-C Drug Forecasted Revenue by Type (2023-2028)
        4.2.3 Global IBS-C Drug Revenue Market Share by Type (2017-2028)
    4.3 Global IBS-C Drug Price by Type
        4.3.1 Global IBS-C Drug Price by Type (2017-2022)
        4.3.2 Global IBS-C Drug Price Forecast by Type (2023-2028)
5 Market Size by Distribution Channel
    5.1 Global IBS-C Drug Sales by Distribution Channel
        5.1.1 Global IBS-C Drug Historical Sales by Distribution Channel (2017-2022)
        5.1.2 Global IBS-C Drug Forecasted Sales by Distribution Channel (2023-2028)
        5.1.3 Global IBS-C Drug Sales Market Share by Distribution Channel (2017-2028)
    5.2 Global IBS-C Drug Revenue by Distribution Channel
        5.2.1 Global IBS-C Drug Historical Revenue by Distribution Channel (2017-2022)
        5.2.2 Global IBS-C Drug Forecasted Revenue by Distribution Channel (2023-2028)
        5.2.3 Global IBS-C Drug Revenue Market Share by Distribution Channel (2017-2028)
    5.3 Global IBS-C Drug Price by Distribution Channel
        5.3.1 Global IBS-C Drug Price by Distribution Channel (2017-2022)
        5.3.2 Global IBS-C Drug Price Forecast by Distribution Channel (2023-2028)
6 North America
    6.1 North America IBS-C Drug Market Size by Type
        6.1.1 North America IBS-C Drug Sales by Type (2017-2028)
        6.1.2 North America IBS-C Drug Revenue by Type (2017-2028)
    6.2 North America IBS-C Drug Market Size by Distribution Channel
        6.2.1 North America IBS-C Drug Sales by Distribution Channel (2017-2028)
        6.2.2 North America IBS-C Drug Revenue by Distribution Channel (2017-2028)
    6.3 North America IBS-C Drug Market Size by Country
        6.3.1 North America IBS-C Drug Sales by Country (2017-2028)
        6.3.2 North America IBS-C Drug Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe IBS-C Drug Market Size by Type
        7.1.1 Europe IBS-C Drug Sales by Type (2017-2028)
        7.1.2 Europe IBS-C Drug Revenue by Type (2017-2028)
    7.2 Europe IBS-C Drug Market Size by Distribution Channel
        7.2.1 Europe IBS-C Drug Sales by Distribution Channel (2017-2028)
        7.2.2 Europe IBS-C Drug Revenue by Distribution Channel (2017-2028)
    7.3 Europe IBS-C Drug Market Size by Country
        7.3.1 Europe IBS-C Drug Sales by Country (2017-2028)
        7.3.2 Europe IBS-C Drug Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific IBS-C Drug Market Size by Type
        8.1.1 Asia Pacific IBS-C Drug Sales by Type (2017-2028)
        8.1.2 Asia Pacific IBS-C Drug Revenue by Type (2017-2028)
    8.2 Asia Pacific IBS-C Drug Market Size by Distribution Channel
        8.2.1 Asia Pacific IBS-C Drug Sales by Distribution Channel (2017-2028)
        8.2.2 Asia Pacific IBS-C Drug Revenue by Distribution Channel (2017-2028)
    8.3 Asia Pacific IBS-C Drug Market Size by Region
        8.3.1 Asia Pacific IBS-C Drug Sales by Region (2017-2028)
        8.3.2 Asia Pacific IBS-C Drug Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America IBS-C Drug Market Size by Type
        9.1.1 Latin America IBS-C Drug Sales by Type (2017-2028)
        9.1.2 Latin America IBS-C Drug Revenue by Type (2017-2028)
    9.2 Latin America IBS-C Drug Market Size by Distribution Channel
        9.2.1 Latin America IBS-C Drug Sales by Distribution Channel (2017-2028)
        9.2.2 Latin America IBS-C Drug Revenue by Distribution Channel (2017-2028)
    9.3 Latin America IBS-C Drug Market Size by Country
        9.3.1 Latin America IBS-C Drug Sales by Country (2017-2028)
        9.3.2 Latin America IBS-C Drug Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa IBS-C Drug Market Size by Type
        10.1.1 Middle East and Africa IBS-C Drug Sales by Type (2017-2028)
        10.1.2 Middle East and Africa IBS-C Drug Revenue by Type (2017-2028)
    10.2 Middle East and Africa IBS-C Drug Market Size by Distribution Channel
        10.2.1 Middle East and Africa IBS-C Drug Sales by Distribution Channel (2017-2028)
        10.2.2 Middle East and Africa IBS-C Drug Revenue by Distribution Channel (2017-2028)
    10.3 Middle East and Africa IBS-C Drug Market Size by Country
        10.3.1 Middle East and Africa IBS-C Drug Sales by Country (2017-2028)
        10.3.2 Middle East and Africa IBS-C Drug Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Allergan
        11.1.1 Allergan Corporation Information
        11.1.2 Allergan Overview
        11.1.3 Allergan IBS-C Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Allergan IBS-C Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Allergan Recent Developments
    11.2 Takeda
        11.2.1 Takeda Corporation Information
        11.2.2 Takeda Overview
        11.2.3 Takeda IBS-C Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Takeda IBS-C Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Takeda Recent Developments
    11.3 Sucampo Pharmaceuticals
        11.3.1 Sucampo Pharmaceuticals Corporation Information
        11.3.2 Sucampo Pharmaceuticals Overview
        11.3.3 Sucampo Pharmaceuticals IBS-C Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Sucampo Pharmaceuticals IBS-C Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Sucampo Pharmaceuticals Recent Developments
    11.4 IM HealthScience
        11.4.1 IM HealthScience Corporation Information
        11.4.2 IM HealthScience Overview
        11.4.3 IM HealthScience IBS-C Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 IM HealthScience IBS-C Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 IM HealthScience Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 IBS-C Drug Industry Chain Analysis
    12.2 IBS-C Drug Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 IBS-C Drug Production Mode & Process
    12.4 IBS-C Drug Sales and Marketing
        12.4.1 IBS-C Drug Sales Channels
        12.4.2 IBS-C Drug Distributors
    12.5 IBS-C Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 IBS-C Drug Industry Trends
    13.2 IBS-C Drug Market Drivers
    13.3 IBS-C Drug Market Challenges
    13.4 IBS-C Drug Market Restraints
14 Key Findings in The Global IBS-C Drug Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global IBS-C Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Amitiza
    Table 3. Major Manufacturers of Lactulose
    Table 4. Major Manufacturers of Milk of Magnesia
    Table 5. Major Manufacturers of LINZESS (Linaclotide)
    Table 6. Major Manufacturers of Others
    Table 7. Global IBS-C Drug Market Size Growth Rate by Distribution Channel, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global IBS-C Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global IBS-C Drug Sales by Region (2017-2022) & (K Units)
    Table 10. Global IBS-C Drug Sales Market Share by Region (2017-2022)
    Table 11. Global IBS-C Drug Sales by Region (2023-2028) & (K Units)
    Table 12. Global IBS-C Drug Sales Market Share by Region (2023-2028)
    Table 13. Global IBS-C Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global IBS-C Drug Revenue Market Share by Region (2017-2022)
    Table 15. Global IBS-C Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global IBS-C Drug Revenue Market Share by Region (2023-2028)
    Table 17. Global IBS-C Drug Sales by Manufacturers (2017-2022) & (K Units)
    Table 18. Global IBS-C Drug Sales Share by Manufacturers (2017-2022)
    Table 19. Global IBS-C Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global IBS-C Drug Revenue Share by Manufacturers (2017-2022)
    Table 21. IBS-C Drug Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 22. Global IBS-C Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global IBS-C Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IBS-C Drug as of 2021)
    Table 24. IBS-C Drug Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers IBS-C Drug Product Offered
    Table 26. Date of Manufacturers Enter into IBS-C Drug Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global IBS-C Drug Sales by Type (2017-2022) & (K Units)
    Table 29. Global IBS-C Drug Sales by Type (2023-2028) & (K Units)
    Table 30. Global IBS-C Drug Sales Share by Type (2017-2022)
    Table 31. Global IBS-C Drug Sales Share by Type (2023-2028)
    Table 32. Global IBS-C Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global IBS-C Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global IBS-C Drug Revenue Share by Type (2017-2022)
    Table 35. Global IBS-C Drug Revenue Share by Type (2023-2028)
    Table 36. IBS-C Drug Price by Type (2017-2022) & (USD/Unit)
    Table 37. Global IBS-C Drug Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 38. Global IBS-C Drug Sales by Distribution Channel (2017-2022) & (K Units)
    Table 39. Global IBS-C Drug Sales by Distribution Channel (2023-2028) & (K Units)
    Table 40. Global IBS-C Drug Sales Share by Distribution Channel (2017-2022)
    Table 41. Global IBS-C Drug Sales Share by Distribution Channel (2023-2028)
    Table 42. Global IBS-C Drug Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 43. Global IBS-C Drug Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 44. Global IBS-C Drug Revenue Share by Distribution Channel (2017-2022)
    Table 45. Global IBS-C Drug Revenue Share by Distribution Channel (2023-2028)
    Table 46. IBS-C Drug Price by Distribution Channel (2017-2022) & (USD/Unit)
    Table 47. Global IBS-C Drug Price Forecast by Distribution Channel (2023-2028) & (USD/Unit)
    Table 48. North America IBS-C Drug Sales by Type (2017-2022) & (K Units)
    Table 49. North America IBS-C Drug Sales by Type (2023-2028) & (K Units)
    Table 50. North America IBS-C Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America IBS-C Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America IBS-C Drug Sales by Distribution Channel (2017-2022) & (K Units)
    Table 53. North America IBS-C Drug Sales by Distribution Channel (2023-2028) & (K Units)
    Table 54. North America IBS-C Drug Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 55. North America IBS-C Drug Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 56. North America IBS-C Drug Sales by Country (2017-2022) & (K Units)
    Table 57. North America IBS-C Drug Sales by Country (2023-2028) & (K Units)
    Table 58. North America IBS-C Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America IBS-C Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe IBS-C Drug Sales by Type (2017-2022) & (K Units)
    Table 61. Europe IBS-C Drug Sales by Type (2023-2028) & (K Units)
    Table 62. Europe IBS-C Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe IBS-C Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe IBS-C Drug Sales by Distribution Channel (2017-2022) & (K Units)
    Table 65. Europe IBS-C Drug Sales by Distribution Channel (2023-2028) & (K Units)
    Table 66. Europe IBS-C Drug Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 67. Europe IBS-C Drug Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 68. Europe IBS-C Drug Sales by Country (2017-2022) & (K Units)
    Table 69. Europe IBS-C Drug Sales by Country (2023-2028) & (K Units)
    Table 70. Europe IBS-C Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe IBS-C Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific IBS-C Drug Sales by Type (2017-2022) & (K Units)
    Table 73. Asia Pacific IBS-C Drug Sales by Type (2023-2028) & (K Units)
    Table 74. Asia Pacific IBS-C Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific IBS-C Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific IBS-C Drug Sales by Distribution Channel (2017-2022) & (K Units)
    Table 77. Asia Pacific IBS-C Drug Sales by Distribution Channel (2023-2028) & (K Units)
    Table 78. Asia Pacific IBS-C Drug Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 79. Asia Pacific IBS-C Drug Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 80. Asia Pacific IBS-C Drug Sales by Region (2017-2022) & (K Units)
    Table 81. Asia Pacific IBS-C Drug Sales by Region (2023-2028) & (K Units)
    Table 82. Asia Pacific IBS-C Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific IBS-C Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America IBS-C Drug Sales by Type (2017-2022) & (K Units)
    Table 85. Latin America IBS-C Drug Sales by Type (2023-2028) & (K Units)
    Table 86. Latin America IBS-C Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America IBS-C Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America IBS-C Drug Sales by Distribution Channel (2017-2022) & (K Units)
    Table 89. Latin America IBS-C Drug Sales by Distribution Channel (2023-2028) & (K Units)
    Table 90. Latin America IBS-C Drug Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 91. Latin America IBS-C Drug Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 92. Latin America IBS-C Drug Sales by Country (2017-2022) & (K Units)
    Table 93. Latin America IBS-C Drug Sales by Country (2023-2028) & (K Units)
    Table 94. Latin America IBS-C Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America IBS-C Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa IBS-C Drug Sales by Type (2017-2022) & (K Units)
    Table 97. Middle East and Africa IBS-C Drug Sales by Type (2023-2028) & (K Units)
    Table 98. Middle East and Africa IBS-C Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa IBS-C Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa IBS-C Drug Sales by Distribution Channel (2017-2022) & (K Units)
    Table 101. Middle East and Africa IBS-C Drug Sales by Distribution Channel (2023-2028) & (K Units)
    Table 102. Middle East and Africa IBS-C Drug Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa IBS-C Drug Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa IBS-C Drug Sales by Country (2017-2022) & (K Units)
    Table 105. Middle East and Africa IBS-C Drug Sales by Country (2023-2028) & (K Units)
    Table 106. Middle East and Africa IBS-C Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa IBS-C Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Allergan Corporation Information
    Table 109. Allergan Description and Major Businesses
    Table 110. Allergan IBS-C Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 111. Allergan IBS-C Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Allergan Recent Developments
    Table 113. Takeda Corporation Information
    Table 114. Takeda Description and Major Businesses
    Table 115. Takeda IBS-C Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 116. Takeda IBS-C Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Takeda Recent Developments
    Table 118. Sucampo Pharmaceuticals Corporation Information
    Table 119. Sucampo Pharmaceuticals Description and Major Businesses
    Table 120. Sucampo Pharmaceuticals IBS-C Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 121. Sucampo Pharmaceuticals IBS-C Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Sucampo Pharmaceuticals Recent Developments
    Table 123. IM HealthScience Corporation Information
    Table 124. IM HealthScience Description and Major Businesses
    Table 125. IM HealthScience IBS-C Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 126. IM HealthScience IBS-C Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. IM HealthScience Recent Developments
    Table 128. Key Raw Materials Lists
    Table 129. Raw Materials Key Suppliers Lists
    Table 130. IBS-C Drug Distributors List
    Table 131. IBS-C Drug Customers List
    Table 132. IBS-C Drug Market Trends
    Table 133. IBS-C Drug Market Drivers
    Table 134. IBS-C Drug Market Challenges
    Table 135. IBS-C Drug Market Restraints
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. IBS-C Drug Product Picture
    Figure 3. Global IBS-C Drug Market Share by Type in 2021 & 2028
    Figure 3. Amitiza Product Picture
    Figure 4. Lactulose Product Picture
    Figure 5. Milk of Magnesia Product Picture
    Figure 6. LINZESS (Linaclotide) Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global IBS-C Drug Market Share by Distribution Channel in 2021 & 2028
    Figure 9. Hospital Pharmacies
    Figure 10. Retail Pharmacies
    Figure 11. Online Pharmacies
    Figure 12. IBS-C Drug Report Years Considered
    Figure 13. Global IBS-C Drug Sales 2017-2028 (K Units)
    Figure 14. Global IBS-C Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global IBS-C Drug Revenue 2017-2028 (US$ Million)
    Figure 16. Global IBS-C Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global IBS-C Drug Sales Market Share by Region (2017-2022)
    Figure 18. Global IBS-C Drug Sales Market Share by Region (2023-2028)
    Figure 19. North America IBS-C Drug Sales YoY (2017-2028) & (K Units)
    Figure 20. North America IBS-C Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe IBS-C Drug Sales YoY (2017-2028) & (K Units)
    Figure 22. Europe IBS-C Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific IBS-C Drug Sales YoY (2017-2028) & (K Units)
    Figure 24. Asia-Pacific IBS-C Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America IBS-C Drug Sales YoY (2017-2028) & (K Units)
    Figure 26. Latin America IBS-C Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa IBS-C Drug Sales YoY (2017-2028) & (K Units)
    Figure 28. Middle East & Africa IBS-C Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The IBS-C Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of IBS-C Drug in the World: Market Share by IBS-C Drug Revenue in 2021
    Figure 31. Global IBS-C Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global IBS-C Drug Sales Market Share by Type (2017-2028)
    Figure 33. Global IBS-C Drug Revenue Market Share by Type (2017-2028)
    Figure 34. Global IBS-C Drug Sales Market Share by Distribution Channel (2017-2028)
    Figure 35. Global IBS-C Drug Revenue Market Share by Distribution Channel (2017-2028)
    Figure 36. North America IBS-C Drug Sales Market Share by Type (2017-2028)
    Figure 37. North America IBS-C Drug Revenue Market Share by Type (2017-2028)
    Figure 38. North America IBS-C Drug Sales Market Share by Distribution Channel (2017-2028)
    Figure 39. North America IBS-C Drug Revenue Market Share by Distribution Channel (2017-2028)
    Figure 40. North America IBS-C Drug Sales Share by Country (2017-2028)
    Figure 41. North America IBS-C Drug Revenue Share by Country (2017-2028)
    Figure 42. U.S. IBS-C Drug Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada IBS-C Drug Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe IBS-C Drug Sales Market Share by Type (2017-2028)
    Figure 45. Europe IBS-C Drug Revenue Market Share by Type (2017-2028)
    Figure 46. Europe IBS-C Drug Sales Market Share by Distribution Channel (2017-2028)
    Figure 47. Europe IBS-C Drug Revenue Market Share by Distribution Channel (2017-2028)
    Figure 48. Europe IBS-C Drug Sales Share by Country (2017-2028)
    Figure 49. Europe IBS-C Drug Revenue Share by Country (2017-2028)
    Figure 50. Germany IBS-C Drug Revenue (2017-2028) & (US$ Million)
    Figure 51. France IBS-C Drug Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. IBS-C Drug Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy IBS-C Drug Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia IBS-C Drug Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific IBS-C Drug Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific IBS-C Drug Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific IBS-C Drug Sales Market Share by Distribution Channel (2017-2028)
    Figure 58. Asia Pacific IBS-C Drug Revenue Market Share by Distribution Channel (2017-2028)
    Figure 59. Asia Pacific IBS-C Drug Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific IBS-C Drug Revenue Share by Region (2017-2028)
    Figure 61. China IBS-C Drug Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan IBS-C Drug Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea IBS-C Drug Revenue (2017-2028) & (US$ Million)
    Figure 64. India IBS-C Drug Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia IBS-C Drug Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan IBS-C Drug Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia IBS-C Drug Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand IBS-C Drug Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia IBS-C Drug Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines IBS-C Drug Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America IBS-C Drug Sales Market Share by Type (2017-2028)
    Figure 72. Latin America IBS-C Drug Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America IBS-C Drug Sales Market Share by Distribution Channel (2017-2028)
    Figure 74. Latin America IBS-C Drug Revenue Market Share by Distribution Channel (2017-2028)
    Figure 75. Latin America IBS-C Drug Sales Share by Country (2017-2028)
    Figure 76. Latin America IBS-C Drug Revenue Share by Country (2017-2028)
    Figure 77. Mexico IBS-C Drug Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil IBS-C Drug Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina IBS-C Drug Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa IBS-C Drug Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa IBS-C Drug Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa IBS-C Drug Sales Market Share by Distribution Channel (2017-2028)
    Figure 83. Middle East and Africa IBS-C Drug Revenue Market Share by Distribution Channel (2017-2028)
    Figure 84. Middle East and Africa IBS-C Drug Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa IBS-C Drug Revenue Share by Country (2017-2028)
    Figure 86. Turkey IBS-C Drug Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia IBS-C Drug Revenue (2017-2028) & (US$ Million)
    Figure 88. U.A.E IBS-C Drug Revenue (2017-2028) & (US$ Million)
    Figure 89. IBS-C Drug Value Chain
    Figure 90. IBS-C Drug Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Allergan
Takeda
Sucampo Pharmaceuticals
IM HealthScience
Frequently Asked Questions
IBS-C Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
IBS-C Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
IBS-C Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports